WHO's First Global Map of NCD Inequality Finds Data Gaps
WHO's Oct. 20 report analyses 35 indicators across up to eight inequality dimensions and finds poorer, rural and less-educated groups lag on NCD care.
Dr. Anand Sharma
→Health, medicine, research, and the science of the human body.
Category Writer
Dr. Anand Sharma
Doctor and science communicator.

WHO's Oct. 20 report analyses 35 indicators across up to eight inequality dimensions and finds poorer, rural and less-educated groups lag on NCD care.
Dr. Anand Sharma
→
FDA approved dostarlimab Oct. 19 for dMMR rectal cancer; 68% had a 12-month complete response by investigators but 47% by independent review.
Dr. Anand Sharma
→
EMA's committee backed non-prescription Nyxoid on Oct. 15; the EU recorded at least 7,600 overdose deaths in 2024, and Bulgaria has no take-home naloxone.
Dr. Anand Sharma
→
EMA's committee backed Rasonque on Oct. 15 after a trial in which patients lived a median 12.4 months versus 6.7 on chemotherapy, but the study was open-label.
Dr. Anand Sharma
→
WHO's Oct. 10 notice says Russia's tests found no plague among 5,500+ checks, but the lab worker's fatal illness has no confirmed cause.
Dr. Anand Sharma
→
US measles cases hit 4,080, the most since 1991, while the CDC counts 2 deaths and Pennsylvania alone reports 5 to 6 amid a political dispute.
Dr. Anand Sharma
→
FDA approved pritelivir Oct. 9 for immunocompromised adults whose herpes lesions resist standard drugs; 63% healed by day 28 versus 34% on alternatives.
Dr. Anand Sharma
→
A Nature Medicine analysis of 6.1 million people in 118 countries finds pain rises fastest before 55, and women report more at all 11 body sites.
Dr. Anand Sharma
→
A Lancet Commission launched Oct. 11 names 17 catastrophic health threats to 2100, including AI misuse and nuclear conflict, and leaves out heart disease.
Dr. Anand Sharma
→
FDA's Oct. 8 approval adds atezolizumab to chemotherapy after surgery, halving relapse-or-death hazard in ATOMIC, though overall survival has not yet differed.
Dr. Anand Sharma
→
WHO's first child obesity guidelines, issued Oct. 7, rule out drugs and surgery under age 10 and allow GLP-1s from 10 only after lifestyle care fails.
Dr. Anand Sharma
→
Days after the Nobel Prize, a NEJM trial of 10 blind patients found optogenetic gene therapy plus goggles improved light sensitivity in seven.
Dr. Anand Sharma
→